Global Biologics and Biosimilars Market Insights, Forecast to 2029

Global Biologics and Biosimilars Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Biologics and Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biologics and Biosimilars Sales Estimates and Forecasts 2018-2029
2.2 Global Biologics and Biosimilars Revenue by Region
2.2.1 Global Biologics and Biosimilars Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biologics and Biosimilars Revenue by Region (2018-2023)
2.2.3 Global Biologics and Biosimilars Revenue by Region (2024-2029)
2.2.4 Global Biologics and Biosimilars Revenue Market Share by Region (2018-2029)
2.3 Global Biologics and Biosimilars Sales Estimates and Forecasts 2018-2029
2.4 Global Biologics and Biosimilars Sales by Region
2.4.1 Global Biologics and Biosimilars Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biologics and Biosimilars Sales by Region (2018-2023)
2.4.3 Global Biologics and Biosimilars Sales by Region (2024-2029)
2.4.4 Global Biologics and Biosimilars Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biologics and Biosimilars Sales by Manufacturers
3.1.1 Global Biologics and Biosimilars Sales by Manufacturers (2018-2023)
3.1.2 Global Biologics and Biosimilars Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologics and Biosimilars in 2022
3.2 Global Biologics and Biosimilars Revenue by Manufacturers
3.2.1 Global Biologics and Biosimilars Revenue by Manufacturers (2018-2023)
3.2.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Biologics and Biosimilars Revenue in 2022
3.3 Global Key Players of Biologics and Biosimilars, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Biologics and Biosimilars Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biologics and Biosimilars, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biologics and Biosimilars, Product Offered and Application
3.8 Global Key Manufacturers of Biologics and Biosimilars, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologics and Biosimilars Sales by Type
4.1.1 Global Biologics and Biosimilars Historical Sales by Type (2018-2023)
4.1.2 Global Biologics and Biosimilars Forecasted Sales by Type (2024-2029)
4.1.3 Global Biologics and Biosimilars Sales Market Share by Type (2018-2029)
4.2 Global Biologics and Biosimilars Revenue by Type
4.2.1 Global Biologics and Biosimilars Historical Revenue by Type (2018-2023)
4.2.2 Global Biologics and Biosimilars Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biologics and Biosimilars Revenue Market Share by Type (2018-2029)
4.3 Global Biologics and Biosimilars Price by Type
4.3.1 Global Biologics and Biosimilars Price by Type (2018-2023)
4.3.2 Global Biologics and Biosimilars Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biologics and Biosimilars Sales by Application
5.1.1 Global Biologics and Biosimilars Historical Sales by Application (2018-2023)
5.1.2 Global Biologics and Biosimilars Forecasted Sales by Application (2024-2029)
5.1.3 Global Biologics and Biosimilars Sales Market Share by Application (2018-2029)
5.2 Global Biologics and Biosimilars Revenue by Application
5.2.1 Global Biologics and Biosimilars Historical Revenue by Application (2018-2023)
5.2.2 Global Biologics and Biosimilars Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biologics and Biosimilars Revenue Market Share by Application (2018-2029)
5.3 Global Biologics and Biosimilars Price by Application
5.3.1 Global Biologics and Biosimilars Price by Application (2018-2023)
5.3.2 Global Biologics and Biosimilars Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biologics and Biosimilars Market Size by Type
6.1.1 US & Canada Biologics and Biosimilars Sales by Type (2018-2029)
6.1.2 US & Canada Biologics and Biosimilars Revenue by Type (2018-2029)
6.2 US & Canada Biologics and Biosimilars Market Size by Application
6.2.1 US & Canada Biologics and Biosimilars Sales by Application (2018-2029)
6.2.2 US & Canada Biologics and Biosimilars Revenue by Application (2018-2029)
6.3 US & Canada Biologics and Biosimilars Market Size by Country
6.3.1 US & Canada Biologics and Biosimilars Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biologics and Biosimilars Sales by Country (2018-2029)
6.3.3 US & Canada Biologics and Biosimilars Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biologics and Biosimilars Market Size by Type
7.1.1 Europe Biologics and Biosimilars Sales by Type (2018-2029)
7.1.2 Europe Biologics and Biosimilars Revenue by Type (2018-2029)
7.2 Europe Biologics and Biosimilars Market Size by Application
7.2.1 Europe Biologics and Biosimilars Sales by Application (2018-2029)
7.2.2 Europe Biologics and Biosimilars Revenue by Application (2018-2029)
7.3 Europe Biologics and Biosimilars Market Size by Country
7.3.1 Europe Biologics and Biosimilars Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biologics and Biosimilars Sales by Country (2018-2029)
7.3.3 Europe Biologics and Biosimilars Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biologics and Biosimilars Market Size
8.1.1 China Biologics and Biosimilars Sales (2018-2029)
8.1.2 China Biologics and Biosimilars Revenue (2018-2029)
8.2 China Biologics and Biosimilars Market Size by Application
8.2.1 China Biologics and Biosimilars Sales by Application (2018-2029)
8.2.2 China Biologics and Biosimilars Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biologics and Biosimilars Market Size by Type
9.1.1 Asia Biologics and Biosimilars Sales by Type (2018-2029)
9.1.2 Asia Biologics and Biosimilars Revenue by Type (2018-2029)
9.2 Asia Biologics and Biosimilars Market Size by Application
9.2.1 Asia Biologics and Biosimilars Sales by Application (2018-2029)
9.2.2 Asia Biologics and Biosimilars Revenue by Application (2018-2029)
9.3 Asia Biologics and Biosimilars Sales by Region
9.3.1 Asia Biologics and Biosimilars Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biologics and Biosimilars Revenue by Region (2018-2029)
9.3.3 Asia Biologics and Biosimilars Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biologics and Biosimilars Market Size by Type
10.1.1 Middle East, Africa and Latin America Biologics and Biosimilars Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biologics and Biosimilars Market Size by Application
10.2.1 Middle East, Africa and Latin America Biologics and Biosimilars Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biologics and Biosimilars Sales by Country
10.3.1 Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biologics and Biosimilars Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Roche Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Amgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 AbbVie Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Information
11.4.2 Sanofi-Aventis Overview
11.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sanofi-Aventis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi-Aventis Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Johnson & Johnson Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Pfizer Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Overview
11.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Novo Nordisk Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novo Nordisk Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Overview
11.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Eli Lilly Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly Recent Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Overview
11.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Novartis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Overview
11.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Merck Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Merck Recent Developments
11.11 3sbio
11.11.1 3sbio Company Information
11.11.2 3sbio Overview
11.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 3sbio Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 3sbio Recent Developments
11.12 Changchun High Tech
11.12.1 Changchun High Tech Company Information
11.12.2 Changchun High Tech Overview
11.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Changchun High Tech Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Changchun High Tech Recent Developments
11.13 CP Guojian
11.13.1 CP Guojian Company Information
11.13.2 CP Guojian Overview
11.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 CP Guojian Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CP Guojian Recent Developments
11.14 Biotech
11.14.1 Biotech Company Information
11.14.2 Biotech Overview
11.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Biotech Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Biotech Recent Developments
11.15 Gelgen
11.15.1 Gelgen Company Information
11.15.2 Gelgen Overview
11.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Gelgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Gelgen Recent Developments
11.16 Innovent
11.16.1 Innovent Company Information
11.16.2 Innovent Overview
11.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Innovent Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Innovent Recent Developments
11.17 Dong Bao
11.17.1 Dong Bao Company Information
11.17.2 Dong Bao Overview
11.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Dong Bao Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Dong Bao Recent Developments
11.18 Ganlee
11.18.1 Ganlee Company Information
11.18.2 Ganlee Overview
11.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Ganlee Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Ganlee Recent Developments
11.19 United Laboratories
11.19.1 United Laboratories Company Information
11.19.2 United Laboratories Overview
11.19.3 United Laboratories Biologics and Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 United Laboratories Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 United Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologics and Biosimilars Industry Chain Analysis
12.2 Biologics and Biosimilars Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologics and Biosimilars Production Mode & Process
12.4 Biologics and Biosimilars Sales and Marketing
12.4.1 Biologics and Biosimilars Sales Channels
12.4.2 Biologics and Biosimilars Distributors
12.5 Biologics and Biosimilars Customers
13 Market Dynamics
13.1 Biologics and Biosimilars Industry Trends
13.2 Biologics and Biosimilars Market Drivers
13.3 Biologics and Biosimilars Market Challenges
13.4 Biologics and Biosimilars Market Restraints
14 Key Findings in The Global Biologics and Biosimilars Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Interferon
Table 4. Major Manufacturers of Erythropoietin
Table 5. Major Manufacturers of Insulin
Table 6. Major Manufacturers of Vaccines
Table 7. Major Manufacturers of Others
Table 8. Global Biologics and Biosimilars Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Biologics and Biosimilars Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Biologics and Biosimilars Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Biologics and Biosimilars Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Biologics and Biosimilars Revenue Market Share by Region (2018-2023)
Table 13. Global Biologics and Biosimilars Revenue Market Share by Region (2024-2029)
Table 14. Global Biologics and Biosimilars Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Biologics and Biosimilars Sales by Region (2018-2023) & (K Units)
Table 16. Global Biologics and Biosimilars Sales by Region (2024-2029) & (K Units)
Table 17. Global Biologics and Biosimilars Sales Market Share by Region (2018-2023)
Table 18. Global Biologics and Biosimilars Sales Market Share by Region (2024-2029)
Table 19. Global Biologics and Biosimilars Sales by Manufacturers (2018-2023) & (K Units)
Table 20. Global Biologics and Biosimilars Sales Share by Manufacturers (2018-2023)
Table 21. Global Biologics and Biosimilars Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Biologics and Biosimilars Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Biologics and Biosimilars, Industry Ranking, 2021 VS 2022 VS 2023
Table 24. Biologics and Biosimilars Price by Manufacturers 2018-2023 (USD/Unit)
Table 25. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2022)
Table 27. Global Key Manufacturers of Biologics and Biosimilars, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Biologics and Biosimilars, Product Offered and Application
Table 29. Global Key Manufacturers of Biologics and Biosimilars, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biologics and Biosimilars Sales by Type (2018-2023) & (K Units)
Table 32. Global Biologics and Biosimilars Sales by Type (2024-2029) & (K Units)
Table 33. Global Biologics and Biosimilars Sales Share by Type (2018-2023)
Table 34. Global Biologics and Biosimilars Sales Share by Type (2024-2029)
Table 35. Global Biologics and Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Biologics and Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Biologics and Biosimilars Revenue Share by Type (2018-2023)
Table 38. Global Biologics and Biosimilars Revenue Share by Type (2024-2029)
Table 39. Biologics and Biosimilars Price by Type (2018-2023) & (USD/Unit)
Table 40. Global Biologics and Biosimilars Price Forecast by Type (2024-2029) & (USD/Unit)
Table 41. Global Biologics and Biosimilars Sales by Application (2018-2023) & (K Units)
Table 42. Global Biologics and Biosimilars Sales by Application (2024-2029) & (K Units)
Table 43. Global Biologics and Biosimilars Sales Share by Application (2018-2023)
Table 44. Global Biologics and Biosimilars Sales Share by Application (2024-2029)
Table 45. Global Biologics and Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Biologics and Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Biologics and Biosimilars Revenue Share by Application (2018-2023)
Table 48. Global Biologics and Biosimilars Revenue Share by Application (2024-2029)
Table 49. Biologics and Biosimilars Price by Application (2018-2023) & (USD/Unit)
Table 50. Global Biologics and Biosimilars Price Forecast by Application (2024-2029) & (USD/Unit)
Table 51. US & Canada Biologics and Biosimilars Sales by Type (2018-2023) & (K Units)
Table 52. US & Canada Biologics and Biosimilars Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Biologics and Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Biologics and Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Biologics and Biosimilars Sales by Application (2018-2023) & (K Units)
Table 56. US & Canada Biologics and Biosimilars Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Biologics and Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Biologics and Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Biologics and Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Biologics and Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Biologics and Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Biologics and Biosimilars Sales by Country (2018-2023) & (K Units)
Table 63. US & Canada Biologics and Biosimilars Sales by Country (2024-2029) & (K Units)
Table 64. Europe Biologics and Biosimilars Sales by Type (2018-2023) & (K Units)
Table 65. Europe Biologics and Biosimilars Sales by Type (2024-2029) & (K Units)
Table 66. Europe Biologics and Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Biologics and Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Biologics and Biosimilars Sales by Application (2018-2023) & (K Units)
Table 69. Europe Biologics and Biosimilars Sales by Application (2024-2029) & (K Units)
Table 70. Europe Biologics and Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Biologics and Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Biologics and Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Biologics and Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Biologics and Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Biologics and Biosimilars Sales by Country (2018-2023) & (K Units)
Table 76. Europe Biologics and Biosimilars Sales by Country (2024-2029) & (K Units)
Table 77. China Biologics and Biosimilars Sales by Type (2018-2023) & (K Units)
Table 78. China Biologics and Biosimilars Sales by Type (2024-2029) & (K Units)
Table 79. China Biologics and Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Biologics and Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Biologics and Biosimilars Sales by Application (2018-2023) & (K Units)
Table 82. China Biologics and Biosimilars Sales by Application (2024-2029) & (K Units)
Table 83. China Biologics and Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Biologics and Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Biologics and Biosimilars Sales by Type (2018-2023) & (K Units)
Table 86. Asia Biologics and Biosimilars Sales by Type (2024-2029) & (K Units)
Table 87. Asia Biologics and Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Biologics and Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Biologics and Biosimilars Sales by Application (2018-2023) & (K Units)
Table 90. Asia Biologics and Biosimilars Sales by Application (2024-2029) & (K Units)
Table 91. Asia Biologics and Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Biologics and Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Biologics and Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Biologics and Biosimilars Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Biologics and Biosimilars Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Biologics and Biosimilars Sales by Region (2018-2023) & (K Units)
Table 97. Asia Biologics and Biosimilars Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Biologics and Biosimilars Sales by Type (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Biologics and Biosimilars Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Biologics and Biosimilars Sales by Application (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Biologics and Biosimilars Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Biologics and Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Biologics and Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Biologics and Biosimilars Sales by Country (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Biologics and Biosimilars Sales by Country (2024-2029) & (K Units)
Table 111. Roche Company Information
Table 112. Roche Description and Major Businesses
Table 113. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Roche Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Roche Recent Developments
Table 116. Amgen Company Information
Table 117. Amgen Description and Major Businesses
Table 118. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Amgen Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Amgen Recent Developments
Table 121. AbbVie Company Information
Table 122. AbbVie Description and Major Businesses
Table 123. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. AbbVie Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. AbbVie Recent Developments
Table 126. Sanofi-Aventis Company Information
Table 127. Sanofi-Aventis Description and Major Businesses
Table 128. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. Sanofi-Aventis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Sanofi-Aventis Recent Developments
Table 131. Johnson & Johnson Company Information
Table 132. Johnson & Johnson Description and Major Businesses
Table 133. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 134. Johnson & Johnson Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Johnson & Johnson Recent Developments
Table 136. Pfizer Company Information
Table 137. Pfizer Description and Major Businesses
Table 138. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 139. Pfizer Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Pfizer Recent Developments
Table 141. Novo Nordisk Company Information
Table 142. Novo Nordisk Description and Major Businesses
Table 143. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 144. Novo Nordisk Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Novo Nordisk Recent Developments
Table 146. Eli Lilly Company Information
Table 147. Eli Lilly Description and Major Businesses
Table 148. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 149. Eli Lilly Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Eli Lilly Recent Developments
Table 151. Novartis Company Information
Table 152. Novartis Description and Major Businesses
Table 153. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 154. Novartis Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Novartis Recent Developments
Table 156. Merck Company Information
Table 157. Merck Description and Major Businesses
Table 158. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 159. Merck Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Merck Recent Developments
Table 161. 3sbio Company Information
Table 162. 3sbio Description and Major Businesses
Table 163. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 164. 3sbio Biologics and Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. 3sbio Recent Developments
Table 166. Changchun High Tech Company Information
Table 167. Changchun High Tech Description and Major Businesses
Table 168. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 169. Changchun High Tech Biologic

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs